Molecular targeted therapy for hepatocellular carcinoma: current and future. - Wikidata - wikimedia - TriplyDB

Molecular targeted therapy for hepatocellular carcinoma: current and future.

Molecular targeted therapy for hepatocellular carcinoma: current and future.

http://www.wikidata.org/entity/Q38151670

about

Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis Genetic alterations in hepatocellular carcinoma: An update Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?Systemic therapy for advanced hepatocellular carcinoma: an update.Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin.Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells Loss of plexin-B3 in hepatocellular carcinoma.Tyrosine kinase inhibitors directed against the vascular endothelial growth factor receptor (VEGFR) have distinct cutaneous toxicity profiles: a meta-analysis and review of the literature.Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.The Human Homolog of Drosophila Headcase Acts as a Tumor Suppressor through Its Blocking Effect on the Cell Cycle in Hepatocellular Carcinoma Targeted Regression of Hepatocellular Carcinoma by Cancer-Specific RNA Replacement through MicroRNA Regulation Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway.Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines.Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine.The Spectrum of E2F in Liver Disease--Mediated Regulation in Biology and Cancer.Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma.Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway.Role of Fanconi anemia/BRCA pathway genes in hepatocellular carcinoma chemoresistance.LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-3β-involved Wnt/β-catenin signaling.Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma.Hepatocellular Carcinoma Treatment With Sorafenib: Real-Life Evaluation of Prognostic Factors and a Practical Clue for Patient Management.Integrated multi-omics data analysis identifying novel drug sensitivity-associated molecular targets of hepatocellular carcinoma cells.CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents

P2860

Q26775818-7B352581-CF14-4869-9742-27492141DC21 Q26823512-44C70152-CA0C-4F00-BCA2-B00B8ED3FD14 Q28073241-D9B6247A-894D-4E8C-82B2-4B964A128A1B Q28088454-CCFA73EE-6C94-4A26-9EAE-118AC69E411F Q33593213-B1A25256-18AF-4982-96F3-BF80945FE228 Q33887033-F0B9D2C0-1A52-4BA3-BB7A-15828AFE713D Q34292802-DA937AF2-639D-462E-8D80-EA468379C0DE Q35159658-200B8E82-CB3F-41D4-90C0-2772DEDFB482 Q35553882-54CD0948-1B8C-415D-BE57-3F375374D7AE Q35716344-3C795535-0123-4866-83EB-93C8AD0B48AA Q35769243-3080F11C-B4FB-4289-BBD0-F845FF49FACC Q35865503-960EF8AE-789F-4ED7-82B5-CA0736A1D732 Q36623958-45F49572-3A3D-4D7D-B7DD-2EB9A986DABF Q36962630-F9430B37-2F10-46BD-86D9-29C5DB9F1A90 Q37110450-9CEA2A1F-5140-4A3A-A98E-97202378C7EE Q37578604-3F67AA9C-EEBA-4C5A-AA1D-5BB7545188F0 Q38261140-D7689B70-671B-4444-B73E-957837444A92 Q38633009-F250E477-08CA-4751-A9B2-895AFA4C6FE0 Q38923517-7F47F5E5-AD2D-46FD-A1B9-038AC66E92D6 Q39020596-F70AE2D8-CE34-4B61-AC83-9D690C98D05D Q46961600-D22EB879-ED82-4281-81CA-2EA538DC4A53 Q47261037-8F09E7B3-7FBC-4FC9-9660-AB5E4825B70E Q47300446-54351207-B98F-4079-9ED5-EC7554F1993D Q47661011-342EF33D-065A-4D79-9E4A-8054F88432F4 Q53820145-7E780928-C146-4549-9AD8-1AB08057F7E3 Q55396493-F21E4467-691C-4FF8-A0E6-1F24C2DE998B Q58746251-AAEB93B9-CD53-4901-AF49-E3D4E4F255A8

P2860

Molecular targeted therapy for hepatocellular carcinoma: current and future.

http://www.wikidata.org/entity/Q38151670

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Molecular targeted therapy for hepatocellular carcinoma: current and future.

@en

type

label

Molecular targeted therapy for hepatocellular carcinoma: current and future.

@en

prefLabel

Molecular targeted therapy for hepatocellular carcinoma: current and future.

@en

P1433

Q38151670-986F8455-6251-4A7F-89BF-3A9DF1A6EB22

P1476

Q38151670-7B6C652E-164F-4D09-BBB6-222BF0865B80

P2093

Q38151670-B1079F97-AB52-4298-B475-BC346C752ED9

Q38151670-E5E7313B-8382-4000-AC6D-9C7E05500DDB

P2860

Q38151670-01383D1B-8FA4-4F07-9D89-681041A80C42

Q38151670-031D2279-5C0D-43CE-ADA3-C4E2DEBD8673

Q38151670-03C54D8A-2653-4FFA-BDAC-1613C557178F

Q38151670-0430F17B-D9E8-4D96-82E4-05D15F035196

Q38151670-057C3C14-86C5-4CCA-9D2D-84C35C3E065C

Q38151670-05D45243-BEBB-4047-AFD6-31A9D7F6F931

Q38151670-06867285-5223-44C4-9996-A95DE58091D1

Q38151670-08DF3F8D-8C98-4003-89AF-6F6328AD70E9

Q38151670-0C7CDF25-0B15-4C95-8352-A6C34B6E3AAF

Q38151670-0E9AD043-389A-464C-B9B4-B8C3974CA70C

P304

Q38151670-BDE31BF1-EF21-481F-AC70-8B5EDBE52724

P31

Q38151670-1CFDEE40-DC59-4FE5-A2F3-4F9731E2C21A

P356

Q38151670-0B3B1174-0689-41BD-BCC9-4D3081537978

P407

Q38151670-594D8838-623D-4D5F-854B-8F3E834B0467

P433

Q38151670-50CD4265-6D04-439E-A464-6E34014F0AC8

P478

Q38151670-C2B7E097-B763-457D-BC7F-CCC0FBC9D6A9

P577

Q38151670-FE2D6EFB-2A86-45CA-A1AA-E58623C811AD

P5875

Q38151670-323F5C14-F767-45CB-B7FC-F9D001268435

P698

Q38151670-F33A9BCB-658A-4109-B5BC-5AA26D1B7EE2

P932

Q38151670-938D9692-E28C-491C-A7DD-2DAAB199AD87

P356

WJG.V19.I37.6144

P1433

World Journal of Gastroenterology

P1476

Molecular targeted therapy for hepatocellular carcinoma: current and future.

@en

P2093

Jung Woo Shin

http://www.w3.org/2001/XMLSchema#string

Young-Hwa Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors

Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions

Modes of resistance to anti-angiogenic therapy

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis

Nuclear translocation of β-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype

Sorafenib in advanced hepatocellular carcinoma

Signaling through the JAK/STAT pathway, recent advances and future challenges

Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomas

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration

P304

6144-6155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V19.I37.6144

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257649608

http://www.w3.org/2001/XMLSchema#string

P698

24115810

http://www.w3.org/2001/XMLSchema#string

P932

3787343

http://www.w3.org/2001/XMLSchema#string